CAMP
CAMP4 Therapeutics Corporation
NASDAQ · Healthcare · Biotechnology · US
$4.41
−1.78%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 30.58x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -399.34x
- Price / sales
- 65.64x
- Price / cash flow
- -9.68x
Enterprise value
- Enterprise value
- $192.0M
- EV / sales
- 45.54x
- EV / EBITDA
- -2.62x
- EV / EBIT
- -3.66x
- Market cap
- $276.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026